West Nile virus vaccine - MacroGenics

Drug Profile

West Nile virus vaccine - MacroGenics

Alternative Names: WNV vaccine

Latest Information Update: 21 Jul 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator National Institutes of Health (USA)
  • Developer MacroGenics; National Institutes of Health (USA)
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued West Nile virus infections

Most Recent Events

  • 16 Aug 2005 West Nile Virus vaccine is available for licensing (http://www.macrogenics.com)
  • 21 Feb 2005 Phase-I/II clinical trials in West Nile virus infections prevention in USA (unspecified route)
  • 20 Oct 2004 Preclinical trials in West Nile virus infections prevention in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top